These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9079780)

  • 41. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat.
    Yamaguchi Y; Miyashita H; Tsunekawa H; Mouri A; Kim HC; Saito K; Matsuno T; Kawashima S; Nabeshima T
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1079-87. PubMed ID: 16474004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective efficacy of curcumin in arsenic induced cholinergic dysfunctions in rats.
    Yadav RS; Chandravanshi LP; Shukla RK; Sankhwar ML; Ansari RW; Shukla PK; Pant AB; Khanna VK
    Neurotoxicology; 2011 Dec; 32(6):760-8. PubMed ID: 21839772
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice.
    Bazalakova MH; Wright J; Schneble EJ; McDonald MP; Heilman CJ; Levey AI; Blakely RD
    Genes Brain Behav; 2007 Jul; 6(5):411-24. PubMed ID: 17010154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic, oral aluminum administration to rats: cognition and cholinergic parameters.
    Connor DJ; Jope RS; Harrell LE
    Pharmacol Biochem Behav; 1988 Oct; 31(2):467-74. PubMed ID: 2854266
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of a novel thyrotropin-releasing hormone analogue, JTP-2942, on extracellular acetylcholine and choline levels in the rat frontal cortex and hippocampus.
    Toide K; Shinoda M; Takase M; Iwata K; Yoshida H
    Eur J Pharmacol; 1993 Mar; 233(1):21-8. PubMed ID: 8472746
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.
    Hernandez CM; Terry AV
    Neuroscience; 2005; 130(4):997-1012. PubMed ID: 15652996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurochemical and behavioural effects of muscarinic acetylcholine receptor agonists.
    Spencer DG; van Rooijen LA; Horváth E; Dompert W; Traber J
    Trends Pharmacol Sci; 1988 Feb; Suppl():61-8. PubMed ID: 3074540
    [No Abstract]   [Full Text] [Related]  

  • 49. Behavioral and neurochemical effects of intraventricular AF64A administration in rats.
    Jarrard LE; Kant GJ; Meyerhoff JL; Levy A
    Pharmacol Biochem Behav; 1984 Aug; 21(2):273-80. PubMed ID: 6548313
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
    Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of hydrocortisone on rat heart muscarinic and adrenergic alpha 1, beta 1 and beta 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling.
    Myslivecek J; Rícný J; Kolár F; Tucek S
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):366-76. PubMed ID: 14564448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of central noradrenaline depletion by the selective neurotoxin DSP-4 on the behaviour of the isolated rat in the elevated plus maze and water maze.
    Lapiz MD; Mateo Y; Durkin S; Parker T; Marsden CA
    Psychopharmacology (Berl); 2001 May; 155(3):251-9. PubMed ID: 11432687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prenatal choline deficiency increases choline transporter expression in the septum and hippocampus during postnatal development and in adulthood in rats.
    Mellott TJ; Kowall NW; Lopez-Coviella I; Blusztajn JK
    Brain Res; 2007 Jun; 1151():1-11. PubMed ID: 17399691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine prevents effects of hyperthermia on behavior and increases norepinephrine.
    Lieberman HR; Georgelis JH; Maher TJ; Yeghiayan SK
    Physiol Behav; 2005 Jan; 84(1):33-8. PubMed ID: 15642604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of repeated injection of sublethal doses of soman on behavior and on brain acetylcholine and choline concentrations in the rat.
    Shih TM; Lenz DE; Maxwell DM
    Psychopharmacology (Berl); 1990; 101(4):489-96. PubMed ID: 2388972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Residential maze as a task for testing rats' maze learning ability: effects of hippocampal lesions and cholinergic receptor antagonists.
    Yamada K; Kawai H; Iwasaki T; Ichitani Y
    Neuroreport; 2002 Oct; 13(14):1759-64. PubMed ID: 12395118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary choline manipulations and behavioural modifications in rats in the early stages of aging.
    Fundarò A; Paschero A
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(5):677-88. PubMed ID: 1956994
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of cholinergic drugs on extracellular levels of acetylcholine and choline in rat cortex, hippocampus and striatum studied by brain dialysis.
    Toide K; Arima T
    Eur J Pharmacol; 1989 Dec; 173(2-3):133-41. PubMed ID: 2625133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prenatal choline supplementation advances hippocampal development and enhances MAPK and CREB activation.
    Mellott TJ; Williams CL; Meck WH; Blusztajn JK
    FASEB J; 2004 Mar; 18(3):545-7. PubMed ID: 14715695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined lesions of cholinergic and serotonergic neurons in the rat brain using 192 IgG-saporin and 5,7-dihydroxytryptamine: neurochemical and behavioural characterization.
    Lehmann O; Jeltsch H; Lehnardt O; Pain L; Lazarus C; Cassel JC
    Eur J Neurosci; 2000 Jan; 12(1):67-79. PubMed ID: 10651861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.